Home
World Journal of Advanced Research and Reviews
International Journal with High Impact Factor for fast publication of Research and Review articles

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Reviewer Panel
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

eISSN: 2581-9615 || CODEN: WJARAI || Impact Factor 8.2 ||  CrossRef DOI

Research and review articles are invited for publication in March 2026 (Volume 29, Issue 3) Submit manuscript

Multidrug resistant profiles of clinical isolates of Escherichia coli, Salmonella typhi and Shigella species

Breadcrumb

  • Home
  • Multidrug resistant profiles of clinical isolates of Escherichia coli, Salmonella typhi and Shigella species

David Augustine Aondoackaa 1, *, Samuel Yusuf 1 and Victoria Asibi Aondoackaa 2

1 Department of Microbiology, College of Biological Sciences, Joseph Sarwuan Tarkaa University, P.M.B. 2373, Makurdi, Benue State. Nigeria.
2 Benue State School of Midwifery, P.M.B. 2267. Makurdi, Benue State. Nigeria.
 
Research Article
World Journal of Advanced Research and Reviews, 2024, 21(02), 1617-1627
Article DOI: 10.30574/wjarr.2024.21.2.0566
DOI url: https://doi.org/10.30574/wjarr.2024.21.2.0566
 
Received on 09 January 2024; revised on 31 January 2024; accepted on 03 February 2024
 
In order to determine the antibiotic susceptibility pattern and multi antibiotic resistance index of E.coli, Salmonella typhi and Shigella species, a total of 32 pre-identified clinical isolates were obtained and subjected to conventional biochemical and gram staining reaction for confirmation. Antibiotic susceptibility testing to ten commonly prescribed antibiotics (Amplicin (PN:30 mcg), Gentamicin (GEN:10 mcg), Streptomycin (STR:30 mcg), Septrin (SXT:30 mcg), Nalidixic acid (NAL:30 mcg), Ciprofloxacin (CIP:10 mcg), Augmentin (AU:30 mcg), Reflacin (PEF:10 mcg), Tarivid (OFX:10mcg), and Ceporexin (CEP:10 mcg) was considered using disc agar diffusion method and reported with the Clinical and Laboratory Standard Institute Interpretative chart. Zones of inhibition were measured and Multiple Antibiotic Resistance index was calculated. Salmonella isolates demonstrated a high rate of susceptibility to Tarivid (90%), Reflaxin (90%), Gentamycin (80%), ciprofloxacin (60%), Augmentin (80%) and moderately susceptible to Streptomycin (40%) and Septrin (20%) with high resistance to Nalidixic acid (90%), Amplicin (90%) and Ceporexin (70%). Nearly all Shigella isolates were susceptible to Augmentin (80%), Reflaxin (90%), Tarivid (80%), intermediate susceptibility was also noted in Streptomycin (40%) and Ceporexin (50%) while high resistance to ciprofloxacin (80%), Amplicin (90%), Septrin (70%) and Nalidixi acid (90%). High rate of resistance was observed to nearly five antibiotics in E,coli with low susceptibility rate to all the antibiotics tested. All the isolates had Multiple Antibiotic Resistance index greater than 0.2 and above. This may be as a result of previous exposure to antibiotics and development of resistance to commonly prescribed antibiotics, hence, antimicrobial susceptibility testing is imperative in selecting therapeutic options.
 
Resistance; Bactericidal; Antibiotics; Susceptibility; Sensitivity; Multi-Drug; Inhibitory
 
https://wjarr.com/sites/default/files/fulltext_pdf/WJARR-2024-0566.pdf

Preview Article PDF

David Augustine Aondoackaa, Samuel Yusuf and Victoria Asibi Aondoackaa. Multidrug resistant profiles of clinical isolates of Escherichia coli, Salmonella typhi and Shigella species. World Journal of Advanced Research and Reviews, 2024, 21(2), 1617-1627. Article DOI: https://doi.org/10.30574/wjarr.2024.21.2.0566

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 World Journal of Advanced Research and Reviews - All rights reserved

Developed & Designed by VS Infosolution